Astrotech (ASTC) AI Stock Analysis

• Market Cap: $7.14M
• Dividend Yield: N/A
• Average Volume (3M): 1.07M
• Price to Earnings (P/E): ―
• Beta (1Y): 0.50
• Revenue Growth: -36.96%
• EPS Growth: -17.39%
• Country: US
• Employees: 30
• Sector: Technology
• Sector Strength: 88
• Industry: Aerospace & Defense
• EPS (TTM): -1.67
• Shares Outstanding: 1,758,953
• 10 Day Avg. Volume: 107,046
• 30 Day Avg. Volume: 1,074,035
• PEG Ratio: -0.04
• Price to Book (P/B): 0.44
• Price to Sales (P/S): 9.17
• P/FCF Ratio: -0.70
• Enterprise Value/Market Cap: -0.75
• Enterprise Value/Revenue: -5.95
• Enterprise Value/Gross Profit: -12.52
• Enterprise Value/Ebitda: 0.39
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 41 Neutral
• Price Target: $4.00 ▼(-1.48% Downside)

Astrotech's overall stock score is primarily impacted by its financial performance and technical analysis. The company faces significant financial challenges with ongoing losses and negative cash flow, which are reflected in its low financial performance score. The technical indicators suggest a bearish trend with weak momentum. Additionally, the valuation is unattractive due to a negative P/E ratio and lack of dividend yield.

Astrotech Business Overview & Revenue Model

Company Description

Astrotech Corporation operates as a science and technology development and commercialization company worldwide. It operates through three segments, Astrotech Technologies, Inc. (ATI), 1st Detect Corporation (1st Detect), and AgLAB Inc (AgLAB). The ATI segment owns and licenses the AMS Technology, the platform mass spectrometry technology. The 1st Detect segment manufactures explosives and narcotics trace detectors for use at airports, secured facilities, and borders. This segment provides TRACER 1000, a mass spectrometer based explosives trace detector to replace the explosives trace detectors used at airports, cargo and secured facilities, and borders. The AgLAB segment develops AgLAB-1000, a mass spectrometer for use in the hemp and cannabis market. It also develops BreathTest-1000, a breath analysis tool to screen for volatile organic compound metabolites found in a person's breath. The company was formerly known as SPACEHAB, Inc. and changed its name to Astrotech Corporation in 2009. Astrotech Corporation was incorporated in 1984 is based in Austin, Texas.

How the Company Makes Money

Astrotech generates revenue through multiple streams including the sale of satellite systems and launch services to government agencies and commercial customers. The company also earns income from partnerships with other aerospace firms and organizations, which may involve collaborative projects or joint ventures in space technology development. Additionally, Astrotech may engage in contractual agreements for research and development services, which further contribute to its overall earnings. The company's ability to secure contracts with federal agencies and private sector clients is a critical factor in its revenue model, ensuring a steady flow of income from its core operations.

Astrotech Financial Statement Overview

Summary

Astrotech is experiencing growth in revenue but continues to struggle with profitability and cash flow. The company's low leverage is a positive aspect, but the negative return on equity and persistent losses highlight significant financial challenges. Continued focus on improving operational efficiency and profitability is essential for future stability.

Income Statement

Astrotech's revenue has shown some growth, with a 16.17% increase in the latest year. However, the company continues to face significant challenges in profitability, with negative net profit margins and EBIT margins. The gross profit margin has improved slightly, but the overall financial health is hindered by persistent losses.

Balance Sheet

The company's debt-to-equity ratio is low, indicating conservative leverage. However, the return on equity is negative, reflecting ongoing losses. The equity ratio is stable, but the company's ability to generate returns on its equity is a concern.

Cash Flow

Astrotech's cash flow situation is challenging, with negative operating and free cash flows. The free cash flow to net income ratio is slightly above 1, indicating some alignment between cash flow and reported earnings, but the negative growth in free cash flow is a concern.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	903.00K	1.05M	1.66M	750.00K	869.00K	334.00K
Gross Profit	429.00K	475.00K	751.00K	306.00K	192.00K	36.00K
EBITDA	-13.84M	-13.85M	-12.41M	-10.57M	-8.36M	-7.31M
Net Income	-13.88M	-13.85M	-11.67M	-9.64M	-8.33M	-7.61M
Balance Sheet
Total Assets	27.49M	26.99M	37.64M	47.67M	56.22M	65.63M
Cash, Cash Equivalents and Short-Term Investments	20.87M	18.21M	31.92M	42.13M	52.63M	63.29M
Total Debt	121.00K	2.68M	300.00K	607.00K	1.04M	2.80M
Total Liabilities	2.74M	4.89M	2.83M	2.96M	2.98M	4.43M
Stockholders Equity	24.75M	22.10M	34.81M	44.72M	53.24M	61.21M
Cash Flow
Free Cash Flow	-13.79M	-13.79M	-10.30M	-9.47M	-7.39M	-7.62M
Operating Cash Flow	-13.08M	-12.95M	-9.72M	-7.63M	-6.79M	-7.41M
Investing Cash Flow	7.61M	5.79M	6.14M	-3.84M	-596.00K	-27.59M
Financing Cash Flow	-202.00K	-185.00K	-181.00K	-776.00K	-2.10M	67.58M

Astrotech Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 4.06
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ASTC, the sentiment is Negative. The current price of 4.06 is below the 20-day moving average (MA) of 4.58, below the 50-day MA of 4.84, and below the 200-day MA of 5.77, indicating a bearish trend. The MACD of -0.27 indicates Positive momentum. The RSI at 39.06 is Neutral, neither overbought nor oversold. The STOCH value of 36.90 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ASTC.

Astrotech Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	―	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
SPCE	―	$230.36M	―	-91.98%	―	-84.19%	55.27%
SIDU	―	$42.30M	―	-157.68%	―	-2.60%	82.24%
ASTC	―	$7.14M	-0.49	-48.68%	―	-36.96%	-17.39%
MNTS	―	$15.13M	-0.10	―	―	-70.65%	90.41%
RDW	―	$1.32B	―	-45.35%	―	-10.50%	-230.68%
EVTL	―	$468.01M	―	―	―	―	―

Astrotech Corporate Events

Astrotech Appoints Nihanth Badugu as New COO

Astrotech Corporation announced the appointment of Mr. Nihanth Badugu as Chief Operating Officer, effective August 13, 2025. Mr. Badugu, who has been with Astrotech since 2023 as Director of Program Management, brings extensive experience from the chemical manufacturing and consulting industries. His previous roles include NPI Program Manager at Thermo Fisher Scientific and Senior Program Manager at PVA Consulting Group. The appointment is part of Astrotech’s growth strategy, with Mr. Badugu’s operational leadership expected to drive further development and value for shareholders.